Susquehanna Fundamental Investments, LLC Aytu Biopharma, Inc Transaction History

Susquehanna Fundamental Investments, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.19 - $3.8 $10,170 - $203,414	-53,530 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$1.08 - $1.55 $19,542 - $28,047	-18,095 Reduced 25.26%	53,530 $58,000
Q4 2021 Feb 14, 2022	SELL	$1.35 - $2.95 $12,472 - $27,255	-9,239 Reduced 11.43%	71,625 $97,000
Q3 2021 Nov 15, 2021	BUY	$2.78 - $5.12 $72,405 - $133,350	26,045 Added 47.51%	80,864 $233,000
Q2 2021 Aug 11, 2021	BUY	$4.73 - $7.56 $65,330 - $104,418	13,812 Added 33.68%	54,819 $275,000
Q1 2021 May 17, 2021	BUY	$6.23 - $9.88 $255,473 - $405,149	41,007 New	41,007 $312,000

Ticker AYTU
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 62,432,700
Market Cap $97.4M
Description
Aytu Biopharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel therapeutics and consumer healthcare products the United States and internationally. The company offers Adzenys XR-ODT for the treatment of attention deficit hyperactivity disorder (ADHD) in patients from 6 years and older; Cotempla XR-ODT f...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.